Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지
DOI QR코드

DOI QR Code

Preliminary Study on the Osteoporosis Improvement Effect of Compounds Isolated from Oryza sativa L. root Extract in the Ovariectomized Mouse Model

난소 적출 마우스 모델에서 Oryza sativa L.의 뿌리 추출물에서 분리된 화합물의 골다공증 개선 효과에 관한 예비연구

  • Received : 2023.03.31
  • Accepted : 2023.04.21
  • Published : 2023.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Bisphosphonates, estrogen, and calcium supplements are commonly used medications for postmenopausal osteoporosis, but they are associated with various side effects such as vaginal bleeding, deep vein thromembolism, and breast cancer. In this study, we aimed to investigate the potential of a compound isolated from the roots of Oryza sativa L. to improve osteoporosis using an ovariectomized mouse model. We isolated and identified oryzativol A, a lignan compound, through chemical analysis of an ethanol extract using a bioassay-guided fractionation protocol. We also examined the metabolism, clearance, and CYP enzyme activity of oryzativol A, and found that it showed plasma stability of over 80% at all analysis times, and indicating a low likelihood of inactivation or excretion by the CYP3A4 enzyme. Our results showed that the high-dose group of oryzativol A exhibited a significant increase in bone mineral density compared to the control group. Although the ALP concentration did not differ significantly compared to the control group, it showed a tendency to increase in the high-dose group of oryzativol A. Furthermore, the abnormal ratio of serum Ca/P, caused by osteoporosis, was improved to a level closer to that of the normal group as the dosage of oryzativol A increased. Taken together, these findings suggest that oryzativol A is stable in vivo and has potential as a therapeutic agent for osteoporosis, particularly when administered in high doses.

Keywords

Acknowledgement

이 논문은 2022학년도 원광대학교의 교비지원에 의해 수행됨

References

  1. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-42. https://doi.org/10.1038/nature01658
  2. Nordin BE, Aaron J, Speed R, Crilly RG. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet. 1981;2(8241):277-9. https://doi.org/10.1016/S0140-6736(81)90526-2
  3. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508-14. https://doi.org/10.1126/science.289.5484.1508
  4. Qin X, Wei Q, An R, Yang Y, Cai M, Han X, Mao H, Gao X. Regulation of bone and fat balance by Fructus Ligustri Lucidi in ovariectomized mice. Pharm Biol. 2023;61(1):391-403. https://doi.org/10.1080/13880209.2023.2168019
  5. Heaney RP. A unified concept of osteoporosis. Am J Med. 1965;39(6):877-80. https://doi.org/10.1016/0002-9343(65)90109-9
  6. Hanley DA, McClung MR, Davison KS, Dian L, Harris ST, Miller PD, Lewiecki EM, Kendler DL; Writing Group for the Western Osteoporosis Alliance. Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis Therapies. Am J Med. 2017;130(7):862.e1-862.e7. https://doi.org/10.1016/j.amjmed.2016.06.016
  7. Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE, Beadnell S, Craig RG, DeRouen T, Desaranayake A, Gilbert A, Gilbert GH, Goldberg K, Hauley R, Hashimoto M, Holmes J, Latzke B, Leroux B, Lindblad A, Richman J, Safford M, Ship J, Thompson VP, Williams OD; CONDOR Collaborative Group; Wanrong Y. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN. Tex Dent J. 2013;130(4):299-307. https://doi.org/10.1007/s00784-012-0880-4
  8. Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 1996;348(9033):983-7. https://doi.org/10.1016/S0140-6736(96)07308-4
  9. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669-76. https://doi.org/10.1038/nrclinonc.2011.110
  10. Khush GS. What it will take to feed 5.0 billion rice consumers in 2030. Plant Mol Biol. 2005;59(1):1-6. https://doi.org/10.1007/s11103-005-2159-5
  11. Hikino H, Murakami M, Oshima Y, Konno C. Isolation and hypoglycemic activity of oryzarans A, B, C, and D: glycans of Oryza sativa roots. Planta Med. 1986;(6):490-2.
  12. Peters RJ. Uncovering the complex metabolic network underlying diterpenoid phytoalexin biosynthesis in rice and other cereal crop plants. Phytochemistry. 2006;67(21):2307-17. https://doi.org/10.1016/j.phytochem.2006.08.009
  13. Kim SJ, Park HR, Park E, Lee SC. Cytotoxic and antitumor activity of momilactone B from rice hulls. J Agric Food Chem. 2007;55(5):1702-6. https://doi.org/10.1021/jf062020b
  14. Prisic S, Xu M, Wilderman PR, Peters RJ. Rice contains two disparate ent-copalyl diphosphate synthases with distinct metabolic functions. Plant Physiol. 2004;136(4):4228-36. https://doi.org/10.1104/pp.104.050567
  15. JCho JG, Huh J, Jeong RH, Cha BJ, Shrestha S, Lee DG, Kang HC, Kim JY, Baek NI. Inhibition effect of phenyl compounds from the Oryza sativa roots on melanin production in murine B16-F10 melanoma cells. Nat Prod Res. 2015;29(11):1052-4.
  16. Park HY, Lee KW, Choi HD. Rice bran constituents: immunomodulatory and therapeutic activities. Food Funct. 2017;8(3):935-943. https://doi.org/10.1039/C6FO01763K
  17. Kim EJ, Kim GY, Kim YE, Jang MK, Kim YI, Kim HW, Chung HW. Effect of Biochemical Makers of Bone Metabolism by Administration of Achyrantes Radix Concentration in Ovariectomized Rats. Korean J. Oriental Physiology & Pathology. 2007;21(4):967-72.
  18. Kang HR, Yun HS, Lee TK, Lee S, Kim SH, Moon E, Park KM, Kim KH. Chemical Characterization of Novel Natural Products from the Roots of Asian Rice ( Oryza sativa) that Control Adipocyte and Osteoblast Differentiation. J Agric Food Chem. 2018;66(11):2677-2684. https://doi.org/10.1021/acs.jafc.7b05030
  19. Chung HY. Osteoporosis Diagnosis and Treatment 2007. Endocrinology and Metabolism. 2008;23(2):76-108. https://doi.org/10.3803/jkes.2008.23.2.76
  20. Nilas L, Christiansen C, Rodbro P. Calcium supplementation and postmenopausal bone loss. Br Med J (Clin Res Ed). 1984;289(6452):1103-6. https://doi.org/10.1136/bmj.289.6452.1103
  21. Kimura T, But PPH, Guo J-X, Sung CK. International Collation of Traditional and Folk Medicine: Northeast Asia part 1; World Scientific, 1996; pp 198-9.
  22. Lee TK, Lee D, Yu JS, Jo MS, Baek SC, Shin MS, Ko YJ, Kang KS, Kim KH. Biological Evaluation of a New Lignan from the Roots of Rice (Oryza sativa). Chem Biodivers. 2018;15(11):e1800333.
  23. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y, Matsumoto T. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology. 2002;143(6):2349-56. https://doi.org/10.1210/endo.143.6.8854
  24. Park H, Yoon L, Kim H-S. Effects of Fermented Soybean Paste Chungkukjang on the Immunoreactivity in Ovariectomized Mice. J Korean Soc Food Sci Nutr. 2013;42(12):1930-39. https://doi.org/10.3746/jkfn.2013.42.12.1930
  25. Lee M-J, Jung H-K, Sim M-O, Jang J-H, Kim T-M, Lee H-J, Lee K-H, An B-K, Cho J-H, Jang M-C, Yong J-H, Kim J-C, Cho H-W. Calcium Bioavailability and Antiosteoporotic Effects of Cheonggukjang Containing High Poly-Gamma Glutamate Contents. Soc Food Sci Nutr. 2016;45(11):1544-51.
  26. Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol. 2012;8(7):379-89. https://doi.org/10.1038/nrrheum.2012.86
  27. Yook T-H, Bae J-S, Kim Y-J, Kim D-K, Jung I-K, Lee C-H. Effects of Cervi Pontotrichum cornu and Carthami semen on the experimental osteoporosis induced by ovariectomy in rats. Korean J. Oriental Physiology & Pathology. 2006;20(5):1226-32.
  28. Kiebzak GM. Age-related bone changes. Exp Gerontol. 1991;26(2-3):171-87. https://doi.org/10.1016/0531-5565(91)90010-J
  29. Yeh JK, Aloia JF, Barilla ML. Effects of 17 beta-estradiol replacement and treadmill exercise on vertebral and femoral bones of the ovariectomized rat. Bone Miner. 1994;24(3):223-34. https://doi.org/10.1016/S0169-6009(08)80139-0
  30. Broulik PD. Tamoxifen prevents bone loss in ovariectomized mice. Endocr Regul. 1991;25(4):217-9.